HC Deb 27 January 1997 vol 289 cc118-9W
Mr. Flynn

To ask the Secretary of State for Health what(a) quantity and (b) percentage of pharmaceuticals for (i) human and (ii) animal use produced in the United Kingdom were donated overseas; and if he will make a statement. [12717]

Mr. Malone

This information is not available.

Mr. Flynn

To ask the Secretary of State for Health (1) what assessment his Department has made of the safety implications of companies donating Pharmaceuticals for(a) human and (b) animal use; and if he will make a statement; [12719]

(2) what regulations his Department has set for the (a) quantities, (b) content, (c) labelling and (d) life span of pharmaceuticals for donation overseas; and if he will make a statement. [12718]

Mr. Malone

Medicines licensed for human and animal use within the European Community are assessed against criteria of safety, quality and efficacy. Countries outside the EC may have particular requirements for the import of pharmaceuticals for human or animal use. The World Health Organisation has issued detailed guidelines for donors and recipients relating to drug donations for international humanitarian relief. The code of ethics of the Royal Pharmaceutical Society of Great Britain provides guidance for pharmacists on the redirection of unwanted medicines to developing countries.

Mr. Flynn

To ask the Secretary of State for Health what financial incentives his Department gives to companies to donate pharmaceuticals overseas; and if he will make a statement. [12716]

Mr. Malone

None.